,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2019_Mouse,RNA transport,17/167,2.122425105932603e-08,4.499541224577119e-06,0,0,6.078787878787879,107.40076215348306,EIF2B5;PRMT5;NUP155;GEMIN2;THOC3;SENP2;RANGAP1;EIF2S1;THOC7;EIF5;EIF3H;ACIN1;EIF3E;SMN1;PABPC1;EIF4B;EIF4G1
1,KEGG_2019_Mouse,Spliceosome,12/132,8.381627706223429e-06,0.0008884525368596834,0,0,5.298913043478261,61.94147671021488,HNRNPM;RBM25;HNRNPK;DDX46;TRA2B;CDC5L;ACIN1;THOC3;SRSF5;HNRNPC;HNRNPA1;SRSF7
2,KEGG_2019_Mouse,Ribosome,12/170,0.00010307258021747268,0.0072837956687014,0,0,4.016648321408916,36.873141497392815,RPL30;RPS28;MRPS9;RPL3;RPL36;RPL35A;RPL37;RPL15;RPL8;MRPL13;RPS24;RPS23
3,KEGG_2019_Mouse,Nucleotide excision repair,6/43,0.0001521984675473627,0.0080665187800102,0,0,8.490966902731609,74.63836017836395,CDK7;RFC4;GTF2H2;MNAT1;GTF2H5;RBX1
4,KEGG_2019_Mouse,Protein processing in endoplasmic reticulum,11/163,0.00029397736906950673,0.012464640448547,0,0,3.818071601768649,31.04858793025205,DNAJC3;HSP90AA1;HSP90AB1;DAD1;LMAN2;DERL1;UBQLN1;UFD1;PDIA6;EIF2S1;RBX1
5,KEGG_2019_Mouse,Huntington disease,11/192,0.0011544873626938,0.0407918868151842,0,0,3.201560137148333,21.655669323078552,COX7A2L;CREBBP;NDUFA7;NDUFB4;NDUFS4;VDAC2;COX6C;SOD2;COX7C;RCOR1;SOD1
6,KEGG_2019_Mouse,Folate biosynthesis,4/26,0.0013772458777283,0.0417108751540573,0,0,9.47678916827853,62.429955101428654,DHFR;MOCS2;PCBD2;GPHN
7,KEGG_2019_Mouse,Ribosome biogenesis in eukaryotes,8/115,0.0015963680284713,0.0423037527544912,0,0,3.9218169028238368,25.256595810224223,TBL3;HEATR1;FCF1;DROSHA;RIOK1;AK6;GTPBP4;GNL3
8,KEGG_2019_Mouse,Alzheimer disease,10/175,0.001947623896477,0.0458773628947933,0,0,3.1867321867321867,19.88885817627021,GSK3B;COX7A2L;NDUFA7;NDUFB4;NDUFS4;MAPK1;CALM1;COX6C;CALM2;COX7C
9,KEGG_2019_Mouse,mRNA surveillance pathway,7/96,0.0023688422705768,0.0470196498925818,0,0,4.118354068138688,24.89690797819397,CPSF6;CPSF3;PAPOLA;ACIN1;PPP2R5C;PABPC1;GSPT1
10,KEGG_2019_Mouse,Cell cycle,8/123,0.0024396988151811,0.0470196498925818,0,0,3.647498831229546,21.94291776260158,GSK3B;CREBBP;CDK7;CDC45;RAD21;MCM4;E2F3;RBX1
11,KEGG_2019_Mouse,Oxidative phosphorylation,8/134,0.0041275803487343,0.0729205861609733,0,0,3.327188940092166,18.266479940637616,ATP6V1A;COX7A2L;NDUFA7;NDUFB4;COX17;NDUFS4;COX6C;COX7C
12,KEGG_2019_Mouse,One carbon pool by folate,3/19,0.0052595646281629,0.0857713616285029,0,0,9.75,51.16514350320168,DHFR;MTHFD1;GART
13,KEGG_2019_Mouse,Non-alcoholic fatty liver disease (NAFLD),8/151,0.0083494284638533,0.1247924514108238,0,0,2.9290924129633806,14.01735390221432,GSK3B;COX7A2L;NDUFA7;NDUFB4;NDUFS4;COX6C;EIF2S1;COX7C
14,KEGG_2019_Mouse,Basal transcription factors,4/43,0.0088296545809545,0.1247924514108238,0,0,5.341243862520458,25.26215733138388,CDK7;GTF2H2;MNAT1;GTF2H5
15,KEGG_2019_Mouse,Renal cell carcinoma,5/68,0.0094519751815446,0.1252386711554665,0,0,4.139047619047619,19.294301044089927,CREBBP;MAPK1;ELOB;PAK2;RBX1
16,KEGG_2019_Mouse,Prostate cancer,6/97,0.0105012415922511,0.1309566598563087,0,0,3.442851266380678,15.686531645873412,GSK3B;CREBBP;HSP90AA1;HSP90AB1;MAPK1;E2F3
17,KEGG_2019_Mouse,RNA polymerase,3/28,0.0156809650201114,0.1846869213479791,0,0,6.237135278514589,25.91721638162741,TWISTNB;POLR1C;POLR3G
18,KEGG_2019_Mouse,Parkinson disease,7/144,0.0203006014720722,0.2265119743199644,0,0,2.6688518815678752,10.400795382621537,COX7A2L;NDUFA7;NDUFB4;NDUFS4;VDAC2;COX6C;COX7C
19,KEGG_2019_Mouse,Citrate cycle (TCA cycle),3/32,0.0224597461940938,0.2380733096573953,0,0,5.375743162901308,20.40648570585789,SUCLA2;PDHB;ACO2
20,KEGG_2019_Mouse,DNA replication,3/35,0.0284327703579718,0.2870355864709535,0,0,4.871021220159151,17.341872648411186,RNASEH2B;RFC4;MCM4
21,KEGG_2019_Mouse,Thermogenesis,9/231,0.0330096803399447,0.3180932832758313,0,0,2.11969111969112,7.230169787169466,COX7A2L;NDUFA7;SMARCB1;NDUFB4;COX17;NDUFS4;NDUFAF2;COX6C;COX7C
22,KEGG_2019_Mouse,Long-term potentiation,4/67,0.0385792363430748,0.3555999175970378,0,0,3.302431610942249,10.749550510661424,CREBBP;MAPK1;CALM1;CALM2
23,KEGG_2019_Mouse,Melanogenesis,5/100,0.0420267129625154,0.3615817540128951,0,0,2.7403508771929825,8.685404649149678,GSK3B;CREBBP;MAPK1;CALM1;CALM2
24,KEGG_2019_Mouse,Bladder cancer,3/41,0.0426393577845395,0.3615817540128951,0,0,4.100656149657964,12.937478135809522,DAPK1;MAPK1;E2F3
25,KEGG_2019_Mouse,Purine metabolism,6/136,0.045604858031302,0.371854996255232,0,0,2.405183052241876,7.426582400749305,ADK;GMPR;NME4;AK6;GART;ADSS
26,KEGG_2019_Mouse,HIF-1 signaling pathway,5/104,0.0483452397552311,0.3795996603003331,0,0,2.629090909090909,7.964535177910969,CREBBP;MAPK1;ELOB;PDHB;RBX1
27,KEGG_2019_Mouse,Pathways in cancer,16/535,0.0505538680935588,0.3827650012798025,0,0,1.6177348662897797,4.828478841984786,GSK3B;RALA;CREBBP;HSP90AA1;HSP90AB1;DAPK1;MGST3;F2R;RUNX1;RBX1;CKS2;MAPK1;E2F3;ELOB;CALM1;CALM2
28,KEGG_2019_Mouse,Glioma,4/75,0.0544869297341181,0.3877897138135106,0,0,2.9291279592448305,8.523160213148438,MAPK1;E2F3;CALM1;CALM2
29,KEGG_2019_Mouse,Fluid shear stress and atherosclerosis,6/143,0.055661617830691,0.3877897138135106,0,0,2.281470783402943,6.589947267541131,HSP90AA1;HSP90AB1;MGST3;CALM1;CALM2;TXN2
30,KEGG_2019_Mouse,Proteasome,3/46,0.0567050996614095,0.3877897138135106,0,0,3.62291036950219,10.39735833847467,PSMA6;PSMC6;PSMA2
31,KEGG_2019_Mouse,Terpenoid backbone biosynthesis,2/23,0.070095635189832,0.4528445536187216,0,0,4.938019652305367,13.124736520915224,GGPS1;ACAT2
32,KEGG_2019_Mouse,Oocyte meiosis,5/116,0.0704899541010274,0.4528445536187216,0,0,2.3434234234234235,6.215426968800431,MAPK1;PPP2R5C;CALM1;CALM2;RBX1
33,KEGG_2019_Mouse,Phototransduction,2/27,0.0926077622595162,0.5704807203549785,0,0,4.147089947089947,9.867512479427496,CALM1;CALM2
34,KEGG_2019_Mouse,IL-17 signaling pathway,4/91,0.0952530338345387,0.5704807203549785,0,0,2.388481291269259,5.615841194007632,GSK3B;HSP90AA1;HSP90AB1;MAPK1
35,KEGG_2019_Mouse,NOD-like receptor signaling pathway,7/205,0.096952040892835,0.5704807203549785,0,0,1.8408481598830124,4.295690691653413,HSP90AA1;HSP90AB1;VDAC2;MAPK1;SUGT1;CTSB;TXN2
36,KEGG_2019_Mouse,Lysine degradation,3/59,0.1018350618584075,0.5704807203549785,0,0,2.780030314513073,6.35070351654033,SETD3;NSD1;ACAT2
37,KEGG_2019_Mouse,Autophagy,5/130,0.1022559781768358,0.5704807203549785,0,0,2.079466666666667,4.741757973331279,ATG3;DAPK1;MAPK1;EIF2S1;CTSB
38,KEGG_2019_Mouse,Hepatocellular carcinoma,6/171,0.1082078323386643,0.5803764132984924,0,0,1.891589693728731,4.206330891511325,GSK3B;SMARCB1;MGST3;MAPK1;E2F3;ARID2
39,KEGG_2019_Mouse,Estrogen signaling pathway,5/134,0.1124494333556394,0.5803764132984924,0,0,2.0145736434108525,4.4023503574952185,HSP90AA1;HSP90AB1;MAPK1;CALM1;CALM2
40,KEGG_2019_Mouse,Glyoxylate and dicarboxylate metabolism,2/31,0.1168717811698905,0.5803764132984924,0,0,3.57434774676154,7.672973073779882,ACO2;ACAT2
41,KEGG_2019_Mouse,Propanoate metabolism,2/31,0.1168717811698905,0.5803764132984924,0,0,3.57434774676154,7.672973073779882,SUCLA2;ACAT2
42,KEGG_2019_Mouse,Kaposi sarcoma-associated herpesvirus infection,7/216,0.1186521085078158,0.5803764132984924,0,0,1.7429736906243185,3.715252172838216,ATG3;GSK3B;CREBBP;MAPK1;E2F3;CALM1;CALM2
43,KEGG_2019_Mouse,Ubiquitin mediated proteolysis,5/138,0.123112053647764,0.5803764132984924,0,0,1.953583959899749,4.092094828098015,PPIL2;UBR5;UBE2E1;ELOB;RBX1
44,KEGG_2019_Mouse,T cell receptor signaling pathway,4/101,0.1262769533378768,0.5803764132984924,0,0,2.1411493748629087,4.430632743331968,GSK3B;DLG1;MAPK1;PAK2
45,KEGG_2019_Mouse,Glucagon signaling pathway,4/102,0.1295894954512579,0.5803764132984924,0,0,2.1191923577941814,4.330322807368298,CREBBP;PDHB;CALM1;CALM2
46,KEGG_2019_Mouse,Th17 cell differentiation,4/102,0.1295894954512579,0.5803764132984924,0,0,2.1191923577941814,4.330322807368298,HSP90AA1;HSP90AB1;MAPK1;RUNX1
47,KEGG_2019_Mouse,Apoptosis,5/141,0.13140598036947,0.5803764132984924,0,0,1.9101960784313723,3.8766735270617385,TUBA1B;PARP2;MAPK1;EIF2S1;CTSB
48,KEGG_2019_Mouse,Prion diseases,2/34,0.1359890401793666,0.5883607452658312,0,0,3.238756613756614,6.461905605659938,MAPK1;SOD1
49,KEGG_2019_Mouse,Sulfur relay system,1/8,0.1422900177078547,0.5923845571417083,0,0,7.392762909913306,14.415059137639451,MOCS2
50,KEGG_2019_Mouse,Base excision repair,2/35,0.1425076057274864,0.5923845571417083,0,0,3.1404521404521404,6.1187310408479565,PARP2;APEX1
51,KEGG_2019_Mouse,"Alanine, aspartate and glutamate metabolism",2/37,0.1557339727107236,0.6217856602402797,0,0,2.9606953892668177,5.505727000512628,GLUD1;ADSS
52,KEGG_2019_Mouse,Adherens junction,3/72,0.1570807601693696,0.6217856602402797,0,0,2.254757236766232,4.173544844757087,CREBBP;MAPK1;VCL
53,KEGG_2019_Mouse,Pyruvate metabolism,2/38,0.1624323477566396,0.6217856602402797,0,0,2.878306878306878,5.231304575954055,PDHB;ACAT2
54,KEGG_2019_Mouse,Pancreatic cancer,3/75,0.1709379879613192,0.6217856602402797,0,0,2.160477453580902,3.8163849725773753,RALA;MAPK1;E2F3
55,KEGG_2019_Mouse,Glutamatergic synapse,4/114,0.1719599270098915,0.6217856602402797,0,0,1.8868471953578336,3.32178281126598,SLC38A1;SLC1A3;MAPK1;SLC38A2
56,KEGG_2019_Mouse,Chronic myeloid leukemia,3/76,0.1756331001625624,0.6217856602402797,0,0,2.1307728643581267,3.706177079311375,MAPK1;E2F3;RUNX1
57,KEGG_2019_Mouse,Pertussis,3/76,0.1756331001625624,0.6217856602402797,0,0,2.1307728643581267,3.706177079311375,MAPK1;CALM1;CALM2
58,KEGG_2019_Mouse,Renin secretion,3/76,0.1756331001625624,0.6217856602402797,0,0,2.1307728643581267,3.706177079311375,CALM1;CALM2;CTSB
59,KEGG_2019_Mouse,Ferroptosis,2/40,0.1759770736529093,0.6217856602402797,0,0,2.726538568643832,4.737092351014341,PCBP2;VDAC2
60,KEGG_2019_Mouse,Cardiac muscle contraction,3/78,0.1851288786398627,0.63029449696224,0,0,2.0737400530503978,3.4977836830653044,COX7A2L;COX6C;COX7C
61,KEGG_2019_Mouse,Hepatitis C,5/160,0.1892472320249382,0.63029449696224,0,0,1.6744086021505376,2.78738969583374,GSK3B;MAPK1;E2F3;EIF3E;EIF2S1
62,KEGG_2019_Mouse,Wnt signaling pathway,5/160,0.1892472320249382,0.63029449696224,0,0,1.6744086021505376,2.78738969583374,GSK3B;CREBBP;PRICKLE1;SENP2;RBX1
63,KEGG_2019_Mouse,Synthesis and degradation of ketone bodies,1/11,0.1902775839886007,0.63029449696224,0,0,5.174142480211081,8.585306143515307,ACAT2
64,KEGG_2019_Mouse,Neurotrophin signaling pathway,4/121,0.1986210054322202,0.6478100484866259,0,0,1.7733224222585924,2.866321694506777,GSK3B;MAPK1;CALM1;CALM2
65,KEGG_2019_Mouse,Rap1 signaling pathway,6/209,0.2079482200715421,0.647880416324304,0,0,1.5344959300334553,2.4098739495509824,RALA;F2R;MAPK1;CALM1;CALM2;FYB
66,KEGG_2019_Mouse,Tight junction,5/167,0.2125460704238911,0.647880416324304,0,0,1.6014814814814815,2.480048636448658,ACTR3;DLG1;TUBA1B;RUNX1;MYL12B
67,KEGG_2019_Mouse,ErbB signaling pathway,3/84,0.2143606560370038,0.647880416324304,0,0,1.9195402298850572,2.9562750280899186,GSK3B;MAPK1;PAK2
68,KEGG_2019_Mouse,Influenza A,5/168,0.2159477062064396,0.647880416324304,0,0,1.5915746421267891,2.4394366963016285,DNAJC3;GSK3B;CREBBP;MAPK1;EIF2S1
69,KEGG_2019_Mouse,Gap junction,3/86,0.224316522019074,0.647880416324304,0,0,1.873094500015979,2.799709066686471,TUBA1B;TUBB5;MAPK1
70,KEGG_2019_Mouse,Fc gamma R-mediated phagocytosis,3/87,0.2293282409921884,0.647880416324304,0,0,1.850701023114816,2.725344056932108,MYO10;MAPK1;ASAP1
71,KEGG_2019_Mouse,Regulation of actin cytoskeleton,6/217,0.2322176723639158,0.647880416324304,0,0,1.4757077324682566,2.154651499854026,F2R;MAPK1;IQGAP2;PAK2;VCL;MYL12B
72,KEGG_2019_Mouse,Colorectal cancer,3/88,0.2343607666436696,0.647880416324304,0,0,1.8288344515525043,2.653444225153832,GSK3B;RALA;MAPK1
73,KEGG_2019_Mouse,Cholesterol metabolism,2/49,0.2385813418108428,0.647880416324304,0,0,2.2034222672520545,3.157603199051601,VAPA;VDAC2
74,KEGG_2019_Mouse,FoxO signaling pathway,4/132,0.2427454217575669,0.647880416324304,0,0,1.6200132978723405,2.293520918027662,USP7;CREBBP;MAPK1;SOD2
75,KEGG_2019_Mouse,Necroptosis,5/176,0.2437407393564745,0.647880416324304,0,0,1.5164912280701754,2.140755088094704,GLUD1;HSP90AA1;HSP90AB1;PARP2;VDAC2
76,KEGG_2019_Mouse,Antigen processing and presentation,3/90,0.2444831759714355,0.647880416324304,0,0,1.7866093478459708,2.516633618035709,HSP90AA1;HSP90AB1;CTSB
77,KEGG_2019_Mouse,GABAergic synapse,3/90,0.2444831759714355,0.647880416324304,0,0,1.7866093478459708,2.516633618035709,SLC38A1;SLC38A2;GPHN
78,KEGG_2019_Mouse,GnRH signaling pathway,3/90,0.2444831759714355,0.647880416324304,0,0,1.7866093478459708,2.516633618035709,MAPK1;CALM1;CALM2
79,KEGG_2019_Mouse,Progesterone-mediated oocyte maturation,3/90,0.2444831759714355,0.647880416324304,0,0,1.7866093478459708,2.516633618035709,HSP90AA1;HSP90AB1;MAPK1
80,KEGG_2019_Mouse,TGF-beta signaling pathway,3/91,0.2495705674345905,0.6531970406930024,0,0,1.7662165420786111,2.451532525087794,CREBBP;MAPK1;RBX1
81,KEGG_2019_Mouse,Dopaminergic synapse,4/135,0.2551524442166056,0.6596624167551267,0,0,1.5826701315575766,2.161759782263368,GSK3B;PPP2R5C;CALM1;CALM2
82,KEGG_2019_Mouse,Amyotrophic lateral sclerosis (ALS),2/52,0.2597568550328026,0.6634753405657128,0,0,2.070899470899471,2.7915916601215174,DERL1;SOD1
83,KEGG_2019_Mouse,Viral carcinogenesis,6/229,0.2701416137302526,0.6781204349242337,0,0,1.3954341622503057,1.8263567376938696,CREBBP;USP7;DLG1;HNRNPK;MAPK1;GTF2H2
84,KEGG_2019_Mouse,Insulin signaling pathway,4/139,0.2718879102290559,0.6781204349242337,0,0,1.5354609929078014,1.9997312584920277,GSK3B;MAPK1;CALM1;CALM2
85,KEGG_2019_Mouse,Cellular senescence,5/185,0.2760493543532216,0.678320377800099,0,0,1.44,1.8535328771486843,VDAC2;MAPK1;E2F3;CALM1;CALM2
86,KEGG_2019_Mouse,Nitrogen metabolism,1/17,0.2783673248519274,0.678320377800099,0,0,3.232849604221636,4.134212444867346,GLUD1
87,KEGG_2019_Mouse,Circadian entrainment,3/99,0.2907401583219208,0.6982762612606946,0,0,1.618368700265252,1.9992118607510088,MAPK1;CALM1;CALM2
88,KEGG_2019_Mouse,Human immunodeficiency virus 1 infection,6/238,0.2995193906215755,0.6982762612606946,0,0,1.3406785911856909,1.616290094412427,MAPK1;ELOB;CALM1;CALM2;PAK2;RBX1
89,KEGG_2019_Mouse,Endometrial cancer,2/58,0.3020962819783805,0.6982762612606946,0,0,1.848450491307634,2.212612794529872,GSK3B;MAPK1
90,KEGG_2019_Mouse,Pyrimidine metabolism,2/58,0.3020962819783805,0.6982762612606946,0,0,1.848450491307634,2.212612794529872,NME4;UMPS
91,KEGG_2019_Mouse,Arginine biosynthesis,1/19,0.3055523748562506,0.6982762612606946,0,0,2.8733509234828496,3.406742765099216,GLUD1
92,KEGG_2019_Mouse,Aldosterone synthesis and secretion,3/102,0.3063193032888896,0.6982762612606946,0,0,1.5690860863274656,1.8564285004785404,ATF1;CALM1;CALM2
93,KEGG_2019_Mouse,Adrenergic signaling in cardiomyocytes,4/148,0.3101477190457629,0.6994820897627845,0,0,1.4388297872340423,1.6844475022182912,MAPK1;PPP2R5C;CALM1;CALM2
94,KEGG_2019_Mouse,Phospholipase D signaling pathway,4/149,0.3144359818453617,0.7016887173812282,0,0,1.4288334556126192,1.6531242713959116,RALA;F2R;MAPK1;AGPAT4
95,KEGG_2019_Mouse,Retrograde endocannabinoid signaling,4/150,0.3187294662000268,0.7038609045250592,0,0,1.4189740600408045,1.6224728254951648,NDUFA7;NDUFB4;NDUFS4;MAPK1
96,KEGG_2019_Mouse,Cytosolic DNA-sensing pathway,2/61,0.3231313891557101,0.7062253041341292,0,0,1.7541924491077034,1.9817046506545648,POLR1C;POLR3G
97,KEGG_2019_Mouse,Focal adhesion,5/199,0.3278129750116341,0.7091464357394534,0,0,1.3351202749140894,1.4890757059217294,GSK3B;MAPK1;PAK2;VCL;MYL12B
98,KEGG_2019_Mouse,mTOR signaling pathway,4/154,0.3359439772319542,0.7158671256730893,0,0,1.3808510638297873,1.5062473466164714,ATP6V1A;GSK3B;MAPK1;EIF4B
99,KEGG_2019_Mouse,Central carbon metabolism in cancer,2/64,0.3440028091986218,0.7158671256730893,0,0,1.6690561529271206,1.78105892610242,MAPK1;PDHB
100,KEGG_2019_Mouse,Mismatch repair,1/22,0.3444266359370523,0.7158671256730893,0,0,2.462495288352808,2.624710119878101,RFC4
101,KEGG_2019_Mouse,Proximal tubule bicarbonate reclamation,1/22,0.3444266359370523,0.7158671256730893,0,0,2.462495288352808,2.624710119878101,GLUD1
102,KEGG_2019_Mouse,Aminoacyl-tRNA biosynthesis,2/66,0.3578024944191312,0.723485943510164,0,0,1.6167328042328042,1.6616361616371187,DARS;IARS
103,KEGG_2019_Mouse,Non-small cell lung cancer,2/66,0.3578024944191312,0.723485943510164,0,0,1.6167328042328042,1.6616361616371187,MAPK1;E2F3
104,KEGG_2019_Mouse,C-type lectin receptor signaling pathway,3/112,0.3583303022102228,0.723485943510164,0,0,1.4244031830238726,1.4618651093393096,MAPK1;CALM1;CALM2
105,KEGG_2019_Mouse,Drug metabolism,3/114,0.3686912171146809,0.7271423068660207,0,0,1.398594881353502,1.3955120918724877,MGST3;NME4;UMPS
106,KEGG_2019_Mouse,Amphetamine addiction,2/68,0.37149564024173,0.7271423068660207,0,0,1.5675805675805676,1.5522467303064058,CALM1;CALM2
107,KEGG_2019_Mouse,cAMP signaling pathway,5/211,0.3729189188334366,0.7271423068660207,0,0,1.2565695792880258,1.2394730187290242,CREBBP;F2R;MAPK1;CALM1;CALM2
108,KEGG_2019_Mouse,Thyroid hormone signaling pathway,3/115,0.3738609030584728,0.7271423068660207,0,0,1.386036377415688,1.363681644936092,GSK3B;CREBBP;MAPK1
109,KEGG_2019_Mouse,Acute myeloid leukemia,2/69,0.3782986198749933,0.7290846128499872,0,0,1.5441048724630817,1.500980178295127,MAPK1;RUNX1
110,KEGG_2019_Mouse,B cell receptor signaling pathway,2/72,0.3985172389407505,0.7456007191779517,0,0,1.4777021919879063,1.3594926989640612,GSK3B;MAPK1
111,KEGG_2019_Mouse,Melanoma,2/72,0.3985172389407505,0.7456007191779517,0,0,1.4777021919879063,1.3594926989640612,MAPK1;E2F3
112,KEGG_2019_Mouse,Prolactin signaling pathway,2/72,0.3985172389407505,0.7456007191779517,0,0,1.4777021919879063,1.3594926989640612,GSK3B;MAPK1
113,KEGG_2019_Mouse,Butanoate metabolism,1/27,0.4044532203087945,0.7456007191779517,0,0,1.9884310939719911,1.7999659988855834,ACAT2
114,KEGG_2019_Mouse,Collecting duct acid secretion,1/27,0.4044532203087945,0.7456007191779517,0,0,1.9884310939719911,1.7999659988855834,ATP6V1A
115,KEGG_2019_Mouse,Gastric acid secretion,2/74,0.4118256289039114,0.749043572626277,0,0,1.4365079365079363,1.274405557591109,CALM1;CALM2
116,KEGG_2019_Mouse,cGMP-PKG signaling pathway,4/172,0.4133872547041246,0.749043572626277,0,0,1.2317629179331306,1.0881029786654808,VDAC2;MAPK1;CALM1;CALM2
117,KEGG_2019_Mouse,Sphingolipid signaling pathway,3/124,0.4199272351872238,0.7503114544184282,0,0,1.2823508779621633,1.1126623005941645,CERS5;MAPK1;PPP2R5C
118,KEGG_2019_Mouse,Platelet activation,3/125,0.4249815253869706,0.7503114544184282,0,0,1.2717745792929511,1.0882696919665986,F2R;MAPK1;MYL12B
119,KEGG_2019_Mouse,Fatty acid elongation,1/29,0.4268995309896282,0.7503114544184282,0,0,1.846211835657746,1.5715076697140924,HACD2
120,KEGG_2019_Mouse,Synaptic vesicle cycle,2/77,0.4315105250113447,0.7503114544184282,0,0,1.3788359788359787,1.1588611432020006,ATP6V1A;SLC1A3
121,KEGG_2019_Mouse,Circadian rhythm,1/30,0.4378042302663957,0.7503114544184282,0,0,1.7824583750341187,1.47228108491246,RBX1
122,KEGG_2019_Mouse,Salivary secretion,2/78,0.4379942503000882,0.7503114544184282,0,0,1.3606237816764133,1.1232622770189078,CALM1;CALM2
123,KEGG_2019_Mouse,Tuberculosis,4/178,0.438861416735307,0.7503114544184282,0,0,1.1889214966984594,0.9791619735591,CREBBP;MAPK1;CALM1;CALM2
124,KEGG_2019_Mouse,Axon guidance,4/180,0.4472843910186359,0.7585943271676064,0,0,1.1752901353965184,0.9455922130829412,GSK3B;MAPK1;PAK2;MYL12B
125,KEGG_2019_Mouse,Ras signaling pathway,5/233,0.4552279438296133,0.760213255338497,0,0,1.1340350877192982,0.8924368618981842,RALA;MAPK1;CALM1;CALM2;PAK2
126,KEGG_2019_Mouse,Biosynthesis of unsaturated fatty acids,1/32,0.4589966824685265,0.760213255338497,0,0,1.6672908332624052,1.298339874011827,HACD2
127,KEGG_2019_Mouse,Pentose phosphate pathway,1/32,0.4589966824685265,0.760213255338497,0,0,1.6672908332624052,1.298339874011827,TKT
128,KEGG_2019_Mouse,RNA degradation,2/83,0.4697911737616386,0.7720599134687395,0,0,1.2763080540858318,0.9642086092410522,CNOT2;PABPC1
129,KEGG_2019_Mouse,Peroxisome,2/84,0.4760211837136174,0.7762806995945146,0,0,1.260678797264163,0.9357929483023364,SOD2;SOD1
130,KEGG_2019_Mouse,Calcium signaling pathway,4/189,0.4846583051058603,0.7843325242934532,0,0,1.117596319723979,0.8094874888681102,F2R;VDAC2;CALM1;CALM2
131,KEGG_2019_Mouse,Apelin signaling pathway,3/138,0.4890946986193015,0.7855157280855448,0,0,1.1485411140583557,0.8214356291443516,MAPK1;CALM1;CALM2
132,KEGG_2019_Mouse,Vascular smooth muscle contraction,3/140,0.4986550167563882,0.7893788381206615,0,0,1.1316579217409823,0.787453721347685,MAPK1;CALM1;CALM2
133,KEGG_2019_Mouse,Human T-cell leukemia virus 1 infection,5/245,0.4989470014536256,0.7893788381206615,0,0,1.0766666666666669,0.7485583122590518,CREBBP;DLG1;VDAC2;MAPK1;E2F3
134,KEGG_2019_Mouse,Thyroid cancer,1/37,0.5085566766483628,0.7983744213805881,0,0,1.4353562005277043,0.9705571622535356,MAPK1
135,KEGG_2019_Mouse,Measles,3/144,0.5174999881765762,0.7983744213805881,0,0,1.099328404537502,0.7241779436842253,GSK3B;EIF3H;EIF2S1
136,KEGG_2019_Mouse,Aldosterone-regulated sodium reabsorption,1/38,0.5179113834293476,0.7983744213805881,0,0,1.3964914782856734,0.9188231403336896,MAPK1
137,KEGG_2019_Mouse,PI3K-Akt signaling pathway,7/357,0.5196965573137791,0.7983744213805881,0,0,1.0332439678284182,0.676268696774426,GSK3B;HSP90AA1;HSP90AB1;F2R;MAPK1;PPP2R5C;EIF4B
138,KEGG_2019_Mouse,Small cell lung cancer,2/92,0.5242131190140789,0.7995192894315447,0,0,1.148148148148148,0.741539474512036,CKS2;E2F3
139,KEGG_2019_Mouse,Breast cancer,3/147,0.5313812166255515,0.8003617077832053,0,0,1.076259946949602,0.6804928964390468,GSK3B;MAPK1;E2F3
140,KEGG_2019_Mouse,Human cytomegalovirus infection,5/255,0.5343322839683653,0.8003617077832053,0,0,1.0330666666666666,0.6474614949159448,GSK3B;MAPK1;E2F3;CALM1;CALM2
141,KEGG_2019_Mouse,Fat digestion and absorption,1/40,0.5360913325717696,0.8003617077832053,0,0,1.3247412218388472,0.8259108895504434,ACAT2
142,KEGG_2019_Mouse,Porphyrin and chlorophyll metabolism,1/41,0.5449232381039095,0.8024147365973483,0,0,1.29155672823219,0.7841174466724955,CPOX
143,KEGG_2019_Mouse,Gastric cancer,3/150,0.5450364248585762,0.8024147365973483,0,0,1.0541330590591675,0.6397561490504722,GSK3B;MAPK1;E2F3
144,KEGG_2019_Mouse,Phosphatidylinositol signaling system,2/98,0.5583512863280827,0.816348087596921,0,0,1.0760582010582012,0.6270911766109474,CALM1;CALM2
145,KEGG_2019_Mouse,Oxytocin signaling pathway,3/154,0.5628788695684817,0.81733096129122,0,0,1.0259982082315948,0.5896317574905021,MAPK1;CALM1;CALM2
146,KEGG_2019_Mouse,Hedgehog signaling pathway,1/44,0.5704253487867869,0.8226542445088355,0,0,1.201264036325704,0.6743571604269236,GSK3B
147,KEGG_2019_Mouse,Glycosphingolipid biosynthesis,1/45,0.5786052393646692,0.8254119591025729,0,0,1.17390261453586,0.6422830088918733,ST3GAL6
148,KEGG_2019_Mouse,Longevity regulating pathway,2/102,0.5801244429541669,0.8254119591025729,0,0,1.0328042328042328,0.5623749610993112,SOD2;SOD1
149,KEGG_2019_Mouse,Cushing syndrome,3/159,0.5845751117000003,0.8261994912026671,0,0,0.992858600285656,0.5330359971560431,GSK3B;MAPK1;E2F3
150,KEGG_2019_Mouse,Hepatitis B,3/163,0.60143180874826,0.8281851726672038,0,0,0.9678381962864722,0.4920897030386973,CREBBP;MAPK1;E2F3
151,KEGG_2019_Mouse,Sphingolipid metabolism,1/48,0.6022244757924261,0.8281851726672038,0,0,1.098804244091394,0.557231124042185,CERS5
152,KEGG_2019_Mouse,Tryptophan metabolism,1/48,0.6022244757924261,0.8281851726672038,0,0,1.098804244091394,0.557231124042185,ACAT2
153,KEGG_2019_Mouse,Type II diabetes mellitus,1/48,0.6022244757924261,0.8281851726672038,0,0,1.098804244091394,0.557231124042185,MAPK1
154,KEGG_2019_Mouse,Notch signaling pathway,1/49,0.609800368717879,0.8281851726672038,0,0,1.0758575197889182,0.5321445623166307,CREBBP
155,KEGG_2019_Mouse,Arginine and proline metabolism,1/50,0.617232345667067,0.8281851726672038,0,0,1.0538473964783803,0.5084916467197831,PYCRL
156,KEGG_2019_Mouse,Fatty acid degradation,1/50,0.617232345667067,0.8281851726672038,0,0,1.0538473964783803,0.5084916467197831,ACAT2
157,KEGG_2019_Mouse,N-Glycan biosynthesis,1/50,0.617232345667067,0.8281851726672038,0,0,1.0538473964783803,0.5084916467197831,DAD1
158,KEGG_2019_Mouse,Leukocyte transendothelial migration,2/115,0.6453827537618948,0.860510338349193,0,0,0.9133773470056656,0.3999786464093794,VCL;MYL12B
159,KEGG_2019_Mouse,"Valine, leucine and isoleucine degradation",1/56,0.6589511220922808,0.8731102367722721,0,0,0.9385943871431998,0.3914932725824583,ACAT2
160,KEGG_2019_Mouse,Phagosome,3/180,0.6679274805448209,0.8762199774250976,0,0,0.8741176999505462,0.352772639386154,ATP6V1A;TUBA1B;TUBB5
161,KEGG_2019_Mouse,VEGF signaling pathway,1/58,0.671823826669092,0.8762199774250976,0,0,0.9055686710179142,0.3601982117420994,MAPK1
162,KEGG_2019_Mouse,Transcriptional misregulation in cancer,3/183,0.6787831683077176,0.8762199774250976,0,0,0.8594164456233422,0.3329839460612701,ATF1;CCNT1;RUNX1
163,KEGG_2019_Mouse,Human papillomavirus infection,6/360,0.682974238539791,0.8762199774250976,0,0,0.8731079488806308,0.3329144353729451,ATP6V1A;GSK3B;CREBBP;DLG1;MAPK1;PPP2R5C
164,KEGG_2019_Mouse,Lysosome,2/124,0.6856921435623198,0.8762199774250976,0,0,0.8456067308526325,0.3190698469870308,AP3B1;CTSB
165,KEGG_2019_Mouse,Glycerolipid metabolism,1/61,0.6902298878773174,0.8762199774250976,0,0,0.8601583113456465,0.3188869776519507,AGPAT4
166,KEGG_2019_Mouse,Long-term depression,1/61,0.6902298878773174,0.8762199774250976,0,0,0.8601583113456465,0.3188869776519507,MAPK1
167,KEGG_2019_Mouse,Inflammatory mediator regulation of TRP channels,2/127,0.6982687119023784,0.8805211637827224,0,0,0.8251851851851851,0.2963663123862513,CALM1;CALM2
168,KEGG_2019_Mouse,Basal cell carcinoma,1/63,0.7019248899966042,0.8805211637827224,0,0,0.8323261554174823,0.2945842598095446,GSK3B
169,KEGG_2019_Mouse,Glutathione metabolism,1/64,0.7076061864800199,0.8824265384339072,0,0,0.8190727478326423,0.2832907040824112,MGST3
170,KEGG_2019_Mouse,Metabolism of xenobiotics by cytochrome P450,1/66,0.7186468083017525,0.8866639165437897,0,0,0.793789324132332,0.2622562987765869,MGST3
171,KEGG_2019_Mouse,Glycolysis / Gluconeogenesis,1/67,0.7240101909952557,0.8866639165437897,0,0,0.7817222355480931,0.2524570480177449,PDHB
172,KEGG_2019_Mouse,Leishmaniasis,1/67,0.7240101909952557,0.8866639165437897,0,0,0.7817222355480931,0.2524570480177449,MAPK1
173,KEGG_2019_Mouse,Fc epsilon RI signaling pathway,1/68,0.7292715957294431,0.8866639165437897,0,0,0.7700153585633837,0.243100822771311,MAPK1
174,KEGG_2019_Mouse,Alcoholism,3/199,0.7322442084357215,0.8866639165437897,0,0,0.7886104043739511,0.2457634947841294,MAPK1;CALM1;CALM2
175,KEGG_2019_Mouse,Signaling pathways regulating pluripotency of stem cells,2/137,0.7372061555108225,0.8866639165437897,0,0,0.763668430335097,0.2328331138606024,GSK3B;MAPK1
176,KEGG_2019_Mouse,Proteoglycans in cancer,3/203,0.7444616504400348,0.8866639165437897,0,0,0.7726790450928382,0.2280129027480831,DROSHA;MAPK1;EIF4B
177,KEGG_2019_Mouse,p53 signaling pathway,1/71,0.744463099739597,0.8866639165437897,0,0,0.736901620806634,0.2174537671193337,SIVA1
178,KEGG_2019_Mouse,Bacterial invasion of epithelial cells,1/74,0.758804267222496,0.8986955567104423,0,0,0.7065095601257816,0.1950047050201045,VCL
179,KEGG_2019_Mouse,Salmonella infection,1/78,0.7766847561494994,0.9147620461316326,0,0,0.6696706986944454,0.1692396679556326,MAPK1
180,KEGG_2019_Mouse,Rheumatoid arthritis,1/84,0.8010569272877363,0.929850555179249,0,0,0.6210700321073211,0.1377677817985478,ATP6V1A
181,KEGG_2019_Mouse,Hippo signaling pathway,2/159,0.8079890894671029,0.929850555179249,0,0,0.6559161527314393,0.1398457339372412,GSK3B;DLG1
182,KEGG_2019_Mouse,Th1 and Th2 cell differentiation,1/87,0.8122290758271207,0.929850555179249,0,0,0.5993127569491318,0.1246407914049746,MAPK1
183,KEGG_2019_Mouse,Viral myocarditis,1/87,0.8122290758271207,0.929850555179249,0,0,0.5993127569491318,0.1246407914049746,EIF4G1
184,KEGG_2019_Mouse,Epstein-Barr virus infection,3/229,0.8133389168961065,0.929850555179249,0,0,0.6828712941010774,0.1410862519221737,USP7;PSMC6;E2F3
185,KEGG_2019_Mouse,Complement and coagulation cascades,1/88,0.815812279544058,0.929850555179249,0,0,0.5923937767264125,0.1205941935586141,F2R
186,KEGG_2019_Mouse,Protein digestion and absorption,1/90,0.8227753758794205,0.9327720838846908,0,0,0.5790222643858765,0.1129510594585625,SLC38A2
187,KEGG_2019_Mouse,Chemical carcinogenesis,1/94,0.8359237293827239,0.941663697900391,0,0,0.5540045961358413,0.0992875418915991,MGST3
188,KEGG_2019_Mouse,Glycerophospholipid metabolism,1/97,0.8451423643388208,0.941663697900391,0,0,0.5366094986807388,0.090284648664497,AGPAT4
189,KEGG_2019_Mouse,Choline metabolism in cancer,1/99,0.8509992650004323,0.941663697900391,0,0,0.5256044370254698,0.0848031296976214,MAPK1
190,KEGG_2019_Mouse,Toll-like receptor signaling pathway,1/99,0.8509992650004323,0.941663697900391,0,0,0.5256044370254698,0.0848031296976214,MAPK1
191,KEGG_2019_Mouse,AGE-RAGE signaling pathway in diabetic complications,1/101,0.8566352085009795,0.941663697900391,0,0,0.5150395778364116,0.0796988270927264,MAPK1
192,KEGG_2019_Mouse,Chagas disease (American trypanosomiasis),1/103,0.8620585094402874,0.941663697900391,0,0,0.5048890268508459,0.0749417558103818,MAPK1
193,KEGG_2019_Mouse,Amoebiasis,1/106,0.8698121793032554,0.941663697900391,0,0,0.4903882397286091,0.0683983593760279,VCL
194,KEGG_2019_Mouse,"Parathyroid hormone synthesis, secretion and action",1/107,0.872298893573592,0.941663697900391,0,0,0.4857370438592124,0.0663629230340777,MAPK1
195,KEGG_2019_Mouse,Toxoplasmosis,1/108,0.8747382310059919,0.941663697900391,0,0,0.4811727862303652,0.0643956436220851,MAPK1
196,KEGG_2019_Mouse,Insulin resistance,1/110,0.8794783593597991,0.941663697900391,0,0,0.4722955145118733,0.0606551752233517,GSK3B
197,KEGG_2019_Mouse,TNF signaling pathway,1/110,0.8794783593597991,0.941663697900391,0,0,0.4722955145118733,0.0606551752233517,MAPK1
198,KEGG_2019_Mouse,Cholinergic synapse,1/113,0.8862551848224336,0.9434254039902792,0,0,0.459574067093856,0.0554937298475641,MAPK1
199,KEGG_2019_Mouse,Chemokine signaling pathway,2/197,0.891175339487651,0.9434254039902792,0,0,0.5270655270655271,0.0607253704980994,GSK3B;MAPK1
200,KEGG_2019_Mouse,Natural killer cell mediated cytotoxicity,1/118,0.8967157443441796,0.9434254039902792,0,0,0.4398213923279886,0.0479477285976275,MAPK1
201,KEGG_2019_Mouse,MicroRNAs in cancer,3/281,0.9049138835585652,0.9434254039902792,0,0,0.5536515085014216,0.0553183651377332,CREBBP;HNRNPK;E2F3
202,KEGG_2019_Mouse,AMPK signaling pathway,1/126,0.9114932884532796,0.9434254039902792,0,0,0.4115039577836412,0.0381345030566598,PPP2R5C
203,KEGG_2019_Mouse,Osteoclast differentiation,1/128,0.9148455187742948,0.9434254039902792,0,0,0.4049820289614194,0.0360434248363922,MAPK1
204,KEGG_2019_Mouse,Herpes simplex virus 1 infection,5/433,0.9170158032485508,0.9434254039902792,0,0,0.5978816199376947,0.051794827460939,EIF2B5;SRSF5;SRSF7;EIF2S1;SRPK1
205,KEGG_2019_Mouse,Relaxin signaling pathway,1/131,0.9196378957680604,0.9434254039902792,0,0,0.3955754008524457,0.0331394391656922,MAPK1
206,KEGG_2019_Mouse,Serotonergic synapse,1/132,0.9211748048395648,0.9434254039902792,0,0,0.3925355999113779,0.0322293166954955,MAPK1
207,KEGG_2019_Mouse,JAK-STAT signaling pathway,1/164,0.9575299087753888,0.975943945482608,0,0,0.3149554041148,0.0136685360737241,CREBBP
208,KEGG_2019_Mouse,Endocytosis,2/269,0.9651822284228436,0.9790365187829804,0,0,0.3835087093514059,0.0135909188333668,ASAP1;SH3GL1
209,KEGG_2019_Mouse,MAPK signaling pathway,2/294,0.9768952500465176,0.9861990143326748,0,0,0.3502210625498296,0.0081867145371565,MAPK1;PAK2
210,KEGG_2019_Mouse,Neuroactive ligand-receptor interaction,1/348,0.9988083695495426,0.999995716491518,0,0,0.1465482499828914,0.00017473548789405464,F2R
211,KEGG_2019_Mouse,Olfactory transduction,2/1133,0.999995716491518,0.999995716491518,0,0,0.086494603735983,3.705011622757428e-07,CALM1;CALM2
